APA

Shuch B., Falbo R., Parisi F., Adeniran A., Kluger Y., Kluger H. M. & Jilaveanu L. B. (20160801). MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors. : BioMed research international.

Chicago

Shuch Brian, Falbo Ryan, Parisi Fabio, Adeniran Adebowale, Kluger Yuval, Kluger Harriet M and Jilaveanu Lucia B. 20160801. MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors. : BioMed research international.

Harvard

Shuch B., Falbo R., Parisi F., Adeniran A., Kluger Y., Kluger H. M. and Jilaveanu L. B. (20160801). MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors. : BioMed research international.

MLA

Shuch Brian, Falbo Ryan, Parisi Fabio, Adeniran Adebowale, Kluger Yuval, Kluger Harriet M and Jilaveanu Lucia B. MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors. : BioMed research international. 20160801.